You have full text access to this OnlineOpen article

Therapeutic evaluation of etanercept in a model of traumatic brain injury

  1. Chung-Ching Chio1,†,
  2. Jia-Wei Lin2,3,†,
  3. Ming-Wen Chang4,
  4. Che-Chuan Wang1,
  5. Jinn-Rung Kuo1,5,
  6. Chung-Zhing Yang5,
  7. Ching-Ping Chang5

Article first published online: 28 SEP 2010

DOI: 10.1111/j.1471-4159.2010.06969.x

Issue

Journal of Neurochemistry

Journal of Neurochemistry

Special Issue: Introducing Preclinical Systematic Reviews

Volume 115, Issue 4, pages 921–929, November 2010

Additional Information

How to Cite

Chio, C.-C., Lin, J.-W., Chang, M.-W., Wang, C.-C., Kuo, J.-R., Yang, C.-Z. and Chang, C.-P. (2010), Therapeutic evaluation of etanercept in a model of traumatic brain injury. Journal of Neurochemistry, 115: 921–929. doi: 10.1111/j.1471-4159.2010.06969.x

Author Information

  1. 1

    Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan

  2. 2

    Department of Neurosurgery, Taipei Medical University-Shuang-Ho Hospital, Taipei, Taiwan

  3. 3

    Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan

  4. 4

    Department of Electrical Engineering, Southern Taiwan University, Tainan, Taiwan

  5. 5

    Department of Biotechnology, Southern Taiwan University, Tainan, Taiwan

  1. †

    These authors contributed equally to this study.

*Address correspondence and reprint requests to Ching-Ping Chang, Department of Biotechnology, Southern Taiwan University, Tainan, Taiwan. E-mail: jessica@mail.stut.edu.tw

  1. †

    These authors contributed equally to this study.

Publication History

  1. Issue published online: 21 OCT 2010
  2. Article first published online: 28 SEP 2010
  3. Accepted manuscript online: 25 AUG 2010 11:16AM EST
  4. Received June 21, 2010; revised manuscript received August 4, 2010; accepted August 17, 2010.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (804K)

References

  • Aden U., Favrais G., Plaisant F., Winerdal M., Felderhoff-Mueser U., Lampa J., Lelievre V. and Gressens P. (2010) Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav. Immun. 24, 747–758.
  • Banks W. A. (2004) Are the extracellular [correction of extracelluar] pathways a conduit for the delivery of therapeutics to the brain? Curr. Pharm. Des. 10, 1365–1370.
  • Berg D. J., Kuhn R., Rajewsky K., Muller W., Menon S., Davidson N., Grunig G. and Rennick D. (1995) Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96, 2339–2347.
  • Bullock R., Zauner A., Woodward J. and Young H. F. (1995) Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke 26, 2187–2189.
  • Campbell S. J., Jiang Y., Davis A. E., Farrands R., Holbrook J., Leppert D. and Anthony D. C. (2007) Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response. J. Neurochem. 103, 2245–2255.
    Direct Link:
  • Cartmell T., Ball C., Bristow A. F., Mitchell D. and Poole S. (2003) Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats. J. Physiol. 549, 653–664.
    Direct Link:
  • Chang M. W., Young M. S. and Lin M. T. (2008) An inclined plane system with microcontroller to determine limb motor function of laboratory animals. J. Neurosci. Methods 168, 186–194.
  • Chen S. H., Chang C. Y., Chang H. K., Chen W. C., Lin M. T., Wang J. J., Chen J. C. and Chang F. M. (2009) Premarin stimulates estrogen receptor-alpha to protect against traumatic brain injury in male rats. Crit. Care Med. 37, 3097–3106.
  • Chio C. C., Kuo J. R., Hsiao S. H., Chang C. P. and Lin M. T. (2007) Effect of brain cooling on brain ischemia and damage markers after fluid percussion brain injury in rats. Shock 28, 284–290.
  • Chou Y. T., Lai S. T., Lee C. C. and Lin M. T. (2003) Hypothermia attenuates circulatory shock and cerebral ischemia in experimental heatstroke. Shock 19, 388–393.
  • Ekdahl C. T., Claasen J. H., Bonde S., Kokaia Z. and Lindvall O. (2003) Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl Acad. Sci. USA 100, 13632–13637.
  • Elliott M. J., Maini R. N., Feldmann M., Kalden J. R., Antoni C., Smolen J. S., Leeb B., Breedveld F. C., Macfarlane J. D. and Bijl H. (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105–1110.
  • Francis J., Chu Y., Johnson A. K., Weiss R. M. and Felder R. B. (2004) Acute myocardial infarction induces hypothalamic cytokine synthesis. Am. J. Physiol. Heart Circ. Physiol. 286, H2264–H2271.
  • Genovese T., Mazzon E., Crisafulli C., Di Paola R., Muia C., Bramanti P. and Cuzzocrea S. (2006) Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J. Pharmacol. Exp. Ther. 316, 1006–1016.
  • Hailer N. P., Vogt C., Korf H. W. and Dehghani F. (2005) Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur. J. Neurosci. 21, 2347–2360.
    Direct Link:
  • Hoehn B. D., Palmer T. D. and Steinberg G. K. (2005) Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 36, 2718–2724.
  • Jiang Y., Deacon R., Anthony D. C. and Campbell S. J. (2008) Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol. Dis. 32, 125–132.
  • Kato K., Liu H., Kikuchi S., Myers R. R. and Shubayev V. I. (2010) Immediate anti-tumor necrosis factor-alpha (etanercept) therapy enhances axonal regeneration after sciatic nerve crush. J. Neurosci. Res. 88, 360–368.
    Direct Link:
  • Knoblach S. M., Fan L. and Faden A. I. (1999) Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment. J. Neuroimmunol. 95, 115–125.
  • Kuo J. R., Lo C. J., Chio C. C., Chang C. P. and Lin M. T. (2007) Resuscitation from experimental traumatic brain injury by agmatine therapy. Resuscitation 75, 506–514.
  • Larsson K., Rydevik B. and Olmarker K. (2005) Disc related cytokines inhibit axonal outgrowth from dorsal root ganglion cells in vitro. Spine 30, 621–624.
  • Leon L. R., Kozak W., Rudolph K. and Kluger M. J. (1999) An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. 276, R81–R89.
  • Lucas S. M., Rothwell N. J. and Gibson R. M. (2006) The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147, S232–S240.
    Direct Link:
  • Marchant A., Bruyns C., Vandenabeele P., Ducarme M., Gerard C., Delvaux A., De Groote D., Abramowicz D., Velu T. and Goldman M. (1994) Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24, 1167–1171.
    Direct Link:
  • McIntosh T. K., Noble L., Andrews B. and Faden A. I. (1987) Traumatic brain injury in the rat: characterization of a midline fluid-percussion model. Cent. Nerv. Syst. Trauma 4, 119–134.
  • Neumann H., Schweigreiter R., Yamashita T., Rosenkranz K., Wekerle H. and Barde Y. A. (2002) Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J. Neurosci. 22, 854–862.
  • Nilsson O. G., Saveland H., Boris-Moller F., Brandt L. and Wieloch T. (1996) Increased levels of glutamate in patients with subarachnoid haemorrhage as measured by intracerebral microdialysis. Acta Neurochir. Suppl. 67, 45–47.
  • Paxinos G. and Watson C. (1982) The rat brain in stereotaxic coordinates. New York: Academic Press.
  • Van Der Poll T., De Waal Malefyt R., Coyle S. M. and Lowry S. F. (1997) Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J. Infect. Dis. 175, 118–122.
  • Rennick D. M., Fort M. M. and Davidson N. J. (1997) Studies with IL-10-/- mice: an overview. J. Leukoc. Biol. 61, 389–396.
  • Rosmussen M. (2005) Treatment of elevated intracranial pressure with indomethacin: friend or foe? Acta Anaesthesiol. Scand. 49, 341–350.
    Direct Link:
  • Silver J. and Miller J. H. (2004) Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146–156.
  • Stahel P. F., Shohami E., Younis F. M. et al. (2000) Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J. Cereb. Blood Flow Metab. 20, 369–380.
  • Standiford T. J., Strieter R. M., Lukacs N. W. and Kunkel S. L. (1995) Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155, 2222–2229.
  • Tobinick E. (2010) Perispinal etanercept: a new therapeutic paradigm in neurology. Expert. Rev. Neurother. 10, 985–1002.
  • Tobinick E. L. and Gross H. (2008) Rapid cognitive improvement in Alzheimer’s disease following perispinal etanercept administration. J. Neuroinflammation 5, 2.
  • Wang Y., Lin S. Z., Chiou A. L., Williams L. R. and Hoffer B. J. (1997) Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J. Neurosci. 17, 4341–4348.
  • Wang Q., Fang C. H. and Hasselgren P. O. (2001) Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1013–R1023.
  • Zhou Z., Peng X., Insolera R., Fink D. J. and Mata M. (2009) Interleukin-10 provides direct trophic support to neurons. J. Neurochem. 110, 1617–1627.
    Direct Link:
View Full Article (HTML) Get PDF (804K)